FDA relents from midodrine withdrawal plan
Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.Food and Drug Administration representative Sandy Walsh said in an emailed statement that the agency will continue to...
FDA relents from midodrine withdrawal plan
(AP) -- Federal regulators have backed off a plan to remove a Shire PLC low blood-pressure treatment from the market after warning in August that the drug has not been proven effective.
Mon 6 Sep 10 from PhysOrg
FDA relents from midodrine withdrawal plan, Mon 6 Sep 10 from AP
FDA relents from midodrine withdrawal plan, Mon 6 Sep 10 from R&D Mag
- Pages: 1
Total number of sources: 3
Bookmark
